Blog
How Long Does Wegovy Take to Work? A Week-by-Week Guide
One of the most common questions we hear from people starting Wegovy is simple: how long until I actually see results? The honest answer is that Wegovy works gradually, in step with a carefully staged dosing schedule, and results build over months rather than days. This guide walks through what tends to happen at each stage of treatment, so you know roughly what to expect and why the process is designed the way it is.
Every person responds differently, and this guide describes general patterns based on the standard dosing schedule and published clinical trial data, not a guaranteed timeline for any individual. If you have questions about your own progress, your pharmacist or prescriber is always the best person to ask.
Quick Answer
Wegovy is introduced gradually over around 16 to 17 weeks, moving through several dose increases before reaching the standard maintenance dose. Most people notice appetite changes within the first few weeks, but meaningful weight loss tends to build steadily over several months, with many people continuing to lose weight for a year or more while on treatment.
- Dose increases roughly every four weeks, up to the maintenance dose
- Appetite changes are often noticed early, even at low doses
- Weight loss builds gradually and is not typically rapid or immediate
- Side effects, when they occur, are usually most noticeable around dose increases
Why Wegovy Is Introduced Gradually
Wegovy (semaglutide) is a GLP-1 receptor agonist, which works by mimicking a hormone your gut naturally produces after eating. This hormone slows digestion and signals fullness to the brain, which is why Wegovy can reduce appetite and support weight loss over time. The dose is increased in stages rather than starting at the full amount, because this approach helps the body adjust and reduces the likelihood and severity of digestive side effects such as nausea. Below is a general guide to what each stage of treatment tends to involve.
Week 1 to 4: Starting Dose (0.25mg)
Treatment usually begins at a low starting dose of 0.25mg, taken once a week. This initial dose is not intended to produce significant weight loss on its own. Instead, its main purpose is to allow your body to adjust to the medication and to establish the weekly injection routine.
During this period, some people notice early signs of appetite change, such as feeling full more quickly or thinking about food less often, though this varies from person to person. Digestive side effects, including mild nausea, are most common in the first couple of weeks and often settle as the body adapts. It is common for visible weight change during this stage to be minimal or gradual rather than dramatic.
Week 5 to 8: First Dose Increase (0.5mg)
Around week five, the dose typically increases to 0.5mg. This step often brings a more noticeable reduction in appetite for many people, as the effect on GLP-1 receptors becomes stronger. Some people experience a return of mild digestive symptoms around this increase, similar to what was felt in the first few weeks, as the body adjusts again to the higher dose.
By the end of this period, many people begin to notice steadier, more consistent changes in eating patterns, such as smaller portion sizes feeling satisfying or reduced snacking between meals. Weight loss at this stage tends to become more visible, though the pace still varies considerably between individuals.
Week 9 to 12: Second Dose Increase (1mg)
The dose typically rises again to 1mg around week nine. This is often the point where people start to feel like the medication is “working” in a more tangible way, with continued appetite suppression and, for many, a steady rate of weight loss becoming established. Clinical trial data, such as that from the STEP programme, indicates that a meaningful proportion of overall weight loss tends to build up during this middle phase of dose escalation, though total loss by this stage is usually still well short of the eventual maximum.
As with previous increases, some people notice a short return of digestive side effects, but these are generally milder and shorter-lived than during the initial weeks, as the body has already been through the adjustment process twice before.
Week 13 to 16: Third Dose Increase (1.7mg)
By around week 13, the dose usually increases to 1.7mg, the step just before the standard maintenance dose. At this stage, most people have a good sense of how their body responds to Wegovy, including their typical side effect pattern and the degree of appetite change they experience. Weight loss tends to continue at a fairly steady pace through this period for many people, building on the progress made in earlier weeks.
This stage is also a useful checkpoint for reviewing progress with a pharmacist or prescriber, since by this point there is usually enough data on your individual response to discuss whether the current plan is working well for you or whether any adjustments are needed.
Week 17 Onward: Maintenance Dose (2.4mg)
Most people reach the standard maintenance dose of 2.4mg around week 17, assuming earlier doses have been well tolerated. This is the dose used for longer-term treatment and is the one associated with the greatest average weight loss in clinical trials. Some people remain on a lower dose if the maintenance dose is not well tolerated, and this is a normal part of individualised treatment that your prescriber can guide you through.
From this point, the focus shifts from dose escalation to sustained treatment. Appetite suppression is generally at its most consistent during this phase, and many people describe this as the stage where healthy eating habits and portion control feel easiest to maintain, since the medication is actively supporting reduced hunger.
Month 5 to 6: Building Momentum
By around the five to six month mark, many people are well into the maintenance phase and have an established routine. Weight loss during this period tends to continue steadily for most people, rather than plateauing immediately. Clinical trial data from the STEP programme suggests that a substantial proportion of the total weight loss seen over a full course of treatment builds up during this middle stretch, though the exact pace and total amount varies significantly between individuals based on factors like starting weight, diet, activity levels, and individual response to the medication.
This is often a good time to revisit goals with a pharmacist, discuss any lifestyle adjustments that might support further progress, and check in on how side effects, if any, are being managed.
Month 6 to 12: Continued Progress
Longer-term data from clinical trials, including the STEP 1 study, followed participants for around 68 weeks and found that weight loss continued, on average, well beyond the six-month mark, with many participants reaching their greatest degree of weight loss later in the treatment course rather than earlier. The rate of loss for most people tends to slow gradually compared with the faster early months, but continued, meaningful progress is common through this period for people who remain on treatment and maintain supporting lifestyle habits.
Beyond 12 Months: Plateau and Long-Term Maintenance
Many people reach a natural plateau at some point after a year or so of treatment, where weight stabilises at a new, lower level. This is a normal physiological response rather than a sign that the medication has stopped working, and it typically reflects the body reaching a new balance between calorie intake and expenditure at the reduced weight. Ongoing treatment at this stage is often used to help maintain the weight loss achieved, since stopping Wegovy is associated with a return of appetite and, for many people, gradual weight regain over time. Decisions about long-term treatment, including whether to continue, adjust the dose, or eventually stop, should always be made together with your prescriber.
What Can Affect How Quickly Wegovy Works for You?
While the dosing schedule is broadly the same for most patients, how quickly someone notices results, and how much weight they lose, can vary considerably. Some of the factors that can influence this include:
- Starting weight and body composition
- Diet and how closely it aligns with the reduced-calorie approach Wegovy is intended to support
- Physical activity levels
- Individual metabolic and hormonal factors
- Consistency of taking the injection on the same day each week
- Whether the maintenance dose is well tolerated or needs to be adjusted
Because of this variability, comparing your own progress week-by-week to someone else’s experience, or to average trial figures, is rarely a fair or useful measure. A pharmacist can help you understand whether your individual progress is in a reasonable and expected range.
Frequently Asked Questions
When will I start losing weight on Wegovy?
Many people notice appetite changes within the first few weeks, but visible, steady weight loss usually builds gradually over the first few months as the dose increases toward the maintenance level.
Is it normal not to see much change in the first month?
Yes. The starting dose is low and is primarily intended to help your body adjust, so minimal weight change in the first four weeks is common and not a sign that the medication isn’t working.
What if I don’t reach the maintenance dose because of side effects?
This is not unusual. Some people remain on a lower dose long-term if that is what suits them best. Your prescriber can help find the right balance between effectiveness and tolerability for you.
Does weight loss continue after 12 months?
For many people, yes, though the pace often slows and a natural plateau is common. Continued treatment is generally used to help maintain results rather than to keep producing rapid ongoing loss indefinitely.
What happens if I stop taking Wegovy?
Appetite often returns to previous levels after stopping, and gradual weight regain is common without other supporting lifestyle changes. Any decision to stop treatment should be discussed with your prescriber first.
Getting the Most From Your Treatment
Understanding the pace at which Wegovy is designed to work can help set realistic expectations and reduce frustration in the early weeks, when changes are often subtle rather than dramatic. Sticking to the prescribed dosing schedule, maintaining supportive lifestyle habits, and keeping in touch with your pharmacist or prescriber throughout treatment are all important parts of getting the best possible outcome.
If you would like to discuss your progress on Wegovy, or are considering starting treatment, our team at REX Pharmacy is happy to talk through what to expect.
You can also get in touch with us if you have any questions before booking.
